Beroni Group Ltd (BNIGF)
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Beroni Group Limited
OTC:BNIGFHealthcare · Biotechnology
Mkt Cap-
EV-
Float59K
O/S33.99M
Inst Own-
Net Cash/Sh-
Dilution
MCap-Float59KO/S33.99M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Nov 9, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Nov 6, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Nov 3, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Nov 2, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 30, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 29, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 26, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 23, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 20, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 19, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 16, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 15, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 12, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 9, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 6, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
| Oct 5, 2026 | 0.0064 | 0.0064 | 0.0064 | 0.0064 | 27 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources:
About
Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases.
Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting oncology and cell therapies.
The company has operations in Australia, the United States, China, and Japan.
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
SectorHealthcare
IndustryBiotechnology
ExchangeOTC
Country
AU
IPO Date-
Shares Outstanding33.99M
Authorized Shares
Float59,173
52-Week Range
Volume
Average Daily Volume27
30d Avg
27
60d Avg
27
90d Avg
27
Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...